<DOC>
	<DOCNO>NCT01418352</DOCNO>
	<brief_summary>The goal current trial determine efficacy safety Once-weekly aripiprazole reduce Total Tic Severity child adolescents Tourette 's Disorder .</brief_summary>
	<brief_title>Efficacy &amp; Safety Study Once-weekly Oral Aripiprazole Children Adolescents With Tourette 's Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>7 17 year old , male female DSMIVTR diagnostic criterion TD , confirm KSADSPL , include Diagnostic Supplement 5 Has TTS â‰¥ 20 YGTSS Screening Baseline Presenting tic symptom cause impairment subject 's normal routine , include academic achievement , occupational functioning , social activity , and/or relationship Females childbearing potential must negative pregnancy test , must practice acceptable doublebarrier method contraception must pregnant lactating . Written ICF obtain legally acceptable representative &amp; informed assent Screening applicable trial center 's IRB/IEC The subject , designate guardian ( ) caregiver ( ) able comprehend satisfactorily comply protocol requirement , evaluate investigator . Clinical presentation and/or history , consistent another neurologic condition may accompany abnormal movement . History schizophrenia , bipolar disorder , psychotic disorder . Subject receive psychostimulants treatment ADD/ADHD develop and/or exacerbation tic disorder initiation stimulant treatment . Currently meet DSMIVTR criterion primary mood disorder . Severe OCD , per CYBOCS score &gt; 16 . Taken aripiprazole within 30 day Screening visit . Received investigational agent clinical trial within 30 day prior Screening randomize clinical trial Onceweekly aripiprazole time . History neuroleptic malignant syndrome . Sexually active patient use 2 approved method contraception ; breastfeed pregnant . Risk commit suicide Body weight low 16 kg Taken neuroleptic antiparkinson drug &lt; 14 day prior randomization . Requiring CBT TD trial . Subject meet DSMIVTR criterion significant psychoactive substance use disorder within past 3 month . Positive drug screen Subject require medication allow per protocol Use CYP2D6 CYP3A4 inhibitor CYP3A4 inducer within 14 day prior dose duration trial Inability swallow tablet tolerate oral medication Abnormal laboratory test result , vital sign ECG result</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Tourette 's Disorder</keyword>
	<keyword>tic disorder</keyword>
</DOC>